SBIR/STTR Research Award

SWITCH MECHANISM FOR GENE EXPRESSION IN TRANSGENIC

Award identifier 463536d41830b5a12642eb639627694b60f3810a549d938426f68f839718b322Awarding agency Department of Health and Human Services

Award amount

$500,000

Program and phase

SBIR · Phase II

Award year

1991

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
STRATAGENE
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THIS PROJECT SEEKS TO GENERATE EUKARYOTIC CELLS AND, ULTIMATELY, TRANSGENIC MOUSE STRAINS THAT EXPRESS EXOGENOUS GENES UNDER TIGHT REGULATORY CONTROL OF A BACTERIAL REPRESSOR. THIS HYBRID EUKARYOTIC/PROKARYOTIC SWITCH WILL GREATLY EXTEND THE USEFULNESS OF EXISTING EUKARYOTIC PROMOTERS AND INCREASE THE POTENTIAL FOR GENERATING USEFUL TRANSGENIC ANIMAL MODELS FOR STUDYING AUTOIMMUNE DISEASES, IMMUNE TOLERANCE, MUTAGENICITY, ONCOGENICITY, CELL DIFFERENTIATION, AND GENE EXPRESSION. IN PHASE I, THE COMPONENTS OF THE PROKARYOTIC LAC OPERON WILL BE TESTED IN STABLY TRANSFECTED MOUSE L CELLS. CELLS EXPRESSING THE LAC REPRESSOR WILL THEN BE STABLY TRANSFECTED WITH CHIMERIC GENE CONSTRUCTS CONTAINING THE LACOPERATOR SEQUENCE. WILD-TYPE AND TIGHT-BINDING REPRESSORS AND OPERATOR SEQUENCES WILL BE TESTED. THE EFFICIENCY OF NUCLEAR TRANSPORT OF THE LAC REPRESSOR CONTAINING A SIGNAL PEPTIDE SEQUENCE WILL BE TESTED BY MEASURING THE NUCLEAR CONCENTRATION OF THE LAC REPRESSOR, AND BOTH THE LEVEL OF REPRESSOR EXPRESSION AND THE NUMBER AND RELATIVE POSITIONING OF OPERATOR SEQUENCES WILL BE TESTED. ALTHOUGH THESE EXPERIMENTS WILL FOCUS ON MAXIMAL REPRESSION FOR GENES REQUIRING LOW LEVELS OF EXPRESSION, CONDITIONS FOR MAXIMAL INDUCTION WILL ALSO BE DETERMINED. PRELIMINARY INDUCTION STUDIES WILL BE EXTENDED TO QUANTITATE INDUCER UPTAKE OVER LONG AND SHORT INDUCTION PERIODS. INDUCTION OF THE CHIMERIC GENES WILL OCCUR THROUGH THE EXPOSURE OF AN EXOGENOUS INDUCER INTRODUCED THROUGH THE DRINKING WATER OR BY INTRAPERITONEAL INJECTION.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.